Arcadia Biosciences, Inc. (RKDA)
USD 5.87
(-0.51%)
USD 5.87
(-0.51%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -13.98 Million USD | 10.45% |
| 2022 | -15.61 Million USD | 3.24% |
| 2021 | -16.13 Million USD | -167.74% |
| 2020 | -6.02 Million USD | 79.13% |
| 2019 | -28.87 Million USD | -114.19% |
| 2018 | -13.48 Million USD | 14.18% |
| 2017 | -15.7 Million USD | 19.96% |
| 2016 | -19.62 Million USD | -9.29% |
| 2015 | -17.95 Million USD | 2.09% |
| 2014 | -18.33 Million USD | -38.98% |
| 2013 | -13.19 Million USD | -6.67% |
| 2012 | -12.37 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.42 Million USD | 15.07% |
| 2024 Q2 | 1.06 Million USD | 143.79% |
| 2023 Q3 | -2.56 Million USD | -411.91% |
| 2023 Q2 | 823 Thousand USD | 121.38% |
| 2023 FY | -13.98 Million USD | 10.45% |
| 2023 Q1 | -3.85 Million USD | 11.04% |
| 2023 Q4 | -2.85 Million USD | -11.14% |
| 2022 Q1 | -4.47 Million USD | 51.79% |
| 2022 Q2 | -3.77 Million USD | 15.6% |
| 2022 Q3 | -2.87 Million USD | 23.83% |
| 2022 FY | -15.61 Million USD | 3.24% |
| 2022 Q4 | -4.32 Million USD | -50.43% |
| 2021 Q3 | -2.17 Million USD | 58.66% |
| 2021 Q1 | 2.05 Million USD | -76.87% |
| 2021 FY | -16.13 Million USD | -167.74% |
| 2021 Q4 | -9.28 Million USD | -326.76% |
| 2021 Q2 | -5.26 Million USD | -355.64% |
| 2020 Q2 | -9.68 Million USD | -483.72% |
| 2020 FY | -6.02 Million USD | 79.13% |
| 2020 Q4 | 8.89 Million USD | 239.23% |
| 2020 Q3 | -6.39 Million USD | 34.04% |
| 2020 Q1 | 2.52 Million USD | 140.45% |
| 2019 FY | -28.87 Million USD | -114.19% |
| 2019 Q3 | -14.18 Million USD | -434.84% |
| 2019 Q4 | -6.24 Million USD | 55.99% |
| 2019 Q1 | -12.61 Million USD | -1852.32% |
| 2019 Q2 | 4.23 Million USD | 133.59% |
| 2018 Q1 | -10.61 Million USD | -258.61% |
| 2018 FY | -13.48 Million USD | 14.18% |
| 2018 Q4 | -646 Thousand USD | -114.52% |
| 2018 Q2 | -6.66 Million USD | 37.17% |
| 2018 Q3 | 4.45 Million USD | 166.73% |
| 2017 FY | -15.7 Million USD | 19.96% |
| 2017 Q1 | -4.21 Million USD | 26.14% |
| 2017 Q2 | -4 Million USD | 4.98% |
| 2017 Q3 | -4.52 Million USD | -12.96% |
| 2017 Q4 | -2.96 Million USD | 34.59% |
| 2016 Q1 | -5.19 Million USD | -34.56% |
| 2016 FY | -19.62 Million USD | -9.29% |
| 2016 Q4 | -5.7 Million USD | -36.72% |
| 2016 Q3 | -4.17 Million USD | 8.26% |
| 2016 Q2 | -4.55 Million USD | 12.31% |
| 2015 FY | -17.95 Million USD | 2.09% |
| 2015 Q3 | -4.61 Million USD | -25.62% |
| 2015 Q2 | -3.67 Million USD | 36.64% |
| 2015 Q1 | -5.8 Million USD | -191.9% |
| 2015 Q4 | -3.85 Million USD | 16.5% |
| 2014 Q1 | -3.47 Million USD | -20.99% |
| 2014 Q2 | -5.81 Million USD | -67.17% |
| 2014 Q3 | -7.06 Million USD | -21.56% |
| 2014 FY | -18.33 Million USD | -38.98% |
| 2014 Q4 | -1.98 Million USD | 71.86% |
| 2013 FY | -13.19 Million USD | -6.67% |
| 2013 Q4 | -2.87 Million USD | 22.81% |
| 2013 Q3 | -3.72 Million USD | -12.79% |
| 2013 Q1 | -3.3 Million USD | 0.0% |
| 2013 Q2 | -3.3 Million USD | 0.0% |
| 2012 FY | -12.37 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 3.24 Million USD | 531.065% |
| Muliang Viagoo Technology, Inc. | 1.83 Million USD | 860.233% |
| N2OFF, Inc. | -6.52 Million USD | -114.353% |
| Yield10 Bioscience, Inc. | -14.45 Million USD | 3.279% |